Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds
−Removed: The Company made the following repurchases of its common stock in the nine months ended September 30, 2021:
+Added: The Company made the following repurchases of its common stock in the three months ended March 31, 2022:
Month Shares Purchased Average Price Per Share Total shares purchased as part of publicly announced repurchase plans Maximum number of shares that may be purchased under the plans
2 unchanged sentences
March 2022 — — —
−Removed: April 2021 — — — —
−Removed: May 2021 580 29.53 — —
−Removed: June 2021 424 29.87 — —
−Removed: July 2021 691 29.06 — —
−Removed: August 2021 — — —
−Removed: September 2021 — — —
8,444 $ 32.16 —
2 unchanged sentences
Item 5 – Exhibits
−Removed: Exhibit 3.2 Amendment to the Registrant's Articles of Incorporation (incorporated by reference to Exhibit 3.1 to the Company's Form 8-K filed under item 5.03 on May 1, 2008).
+Added: Exhibit 3.2 Amendment to the Registrant's Articles of Incorporation (incorporated by reference to Exhibit 3.1 to the Company's Form 8-K filed on May 1, 2008).
Exhibit 3.3 Amendment to the Registrant's Articles of Incorporation (incorporated by reference to the Definitive Proxy Statement for the Company's 2008 Annual Meeting filed on March 14, 2008).
3 unchanged sentences
Exhibit 4.1 Description of Capital Stock (incorporated by reference to Exhibit 4.1 to the Company's Form 10-K filed March 5, 2021.
−Removed: Exhibit 10.1 Director Split Dollar Insurance Plan and Specimen Agreement dated January 1, 2016, attached as Exhibit 10.1 to the Company's Form 8-K filed under item 1.01 on October 25, 2017.
−Removed: Exhibit 10.2 Executive Split Dollar Insurance Plan and Specimen Agreement dated January 1, 2016, attached as Exhibit 10.2 to the Company's Form 8-K filed under item 1.01 on October 25, 2017.
+Added: Exhibit 10.1 Director Split Dollar Insurance Plan and Specimen Agreement dated January 1, 2016, attached as Exhibit 10.1 to the Company's Form 8-K filed on October 25, 2017.
+Added: Exhibit 10.2 Executive Split Dollar Insurance Plan and Specimen Agreement dated January 1, 2016, attached as Exhibit 10.2 to the Company's Form 8-K filed on October 25, 2017.
Exhibit 10.3 Amendments dated November 8, 2019 to the Restricted Stock Agreements of an Executive Officer dated January 29, 2015, January 28, 2016, January 26, 2017 and January 4, 2018 attached as Exhibit 10.3 to the Company’s Form 10-Q filed under Part II Item 4A on November 12, 2019.
4 unchanged sentences
Incorporated by reference to Exhibit 14.2 to the Company's Annual Report on Form 10-K filed on March 15, 2006.
−Removed: Exhibit 23.1 Consent of Independent Registered Public Accounting firm on Form 10-K filed on March 5, 2021.
+Added: Exhibit 23.1 Consent of Independent Registered Public Accounting Firm
Exhibit 31.1 Certification of Chief Executive Officer Pursuant to Rule 13A-14(A) of The Securities Exchange Act of 1934
13 unchanged sentences
President & Chief Executive Officer
−Removed: November 5, 2021
/s/ Richard M.
Executive Vice President & Chief Financial Officer
−Removed: November 5, 2021
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.